DGDenis S. Grankin

Denis S. Grankin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Denis S. Grankin has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predictors of the development of residual pulmonary hypertension in patients with chronic thromboembolic pulmonary hypertension

    by Oksana Ya. Vasiltseva, Devran F. Zeinalov, Alexander G. Edemskiy, Алексей Геннадьевич Лавров, Денис Сергеевич Гранкин, Дмитрий Андреевич Сирота, Aleksandr M. Chernyavskiy

    Introduction. After pulmonary endarterectomy (PEA), a third of patients with chronic thromboembolic pulmonary hypertension (CTEPH) develop residual pulmonary hypertension (PH) in the postoperative period, which plays a decisive role in the formation of long-term mortality, but in modern clinical practice there are no tools for predicting its probability. Objective. of the study was to determine predictors of residual pulmonary hypertension after pulmonary endarterectomy. Methods. The retrospective cohort observational study included 353 patients aged 19 to 77 years with CTEPH who underwent PEA at the Federal State Budgetary Institution "National Medical Research Center named after Academician E.N. Meshalkin" from 2004 to 2019. The patients underwent clinical and instrumental examination before PEA, after PEA during the hospital period and in the late period (12 months) after PEA. An analysis of the obtained factors was carried out, non-modifiable and modifiable predictors of residual PH were determined. Results. According to the regression analysis, independent non-modifiable predictors of residual PH after PEA were identified: history of cancer; blood group AB (IV); reperfusion syndrome after PEA; pulmonary vascular resistance >1000 dyn×s×cm–5 according to pulmonary circulation tensiometry data before PEA; the ratio of the systolic excursion of the tricuspid valve annulus to the systolic pressure in the pulmonary artery 50 mmHg after PEA, measured by transthoracic echocardiography during the hospital period; thrombus calcification in the biopsy material of thrombotic masses. In addition, modifiable predictors were identified - delay in diagnosis and treatment of 6 months or more; obesity; smoking; anemia; irregular warfarin intake; failure to achieve target INR values; thrombosis of veins of any localization after LEE in dynamics. Conclusion. For the first time in Russia, modifiable and non-modifiable predictors of residual PH after PEA in patients with CTEPH were identified. An optimization algorithm for early diagnosis and treatment of CTEPH was proposed.

  • Фармакологические эффекты нового стимулятора растворимой гуанилатциклазы на модели тромбоэмболической легочной артериальной гипертензии

    by Владимир Валерьевич Быков, Давид Сергеевич Сергеевичев, Арина Владимировна Быкова, Ксения Алексеевна Рожнева, Валентин Владимирович Ларченко, Сергей Александрович Станкевич, Денис Сергеевич Гранкин, Илья Сергеевич Зыков, Сергей Николаевич Иванов, Дмитрий Сергеевич Кислицин, et al.

    Новый стимулятор растворимой гуанилатциклазы, производное индолинона — соединение GRS, в суточной дозе 40 мг при введении в желудок в течение 5 недель улучшал показатели легочной гемодинамики у свиней породы Минисибс с моделью хронической тромбоэмболической легочной гипертензии. Соединение GRS уменьшало среднее давление в легочной артерии в 1,8 раза и легочно-сосудистое сопротивление – в 2,4 раза, повышало сердечный выброс в 1,6 раза (p < 0,05), нормализовало конечные диастолические размеры правого желудочка и предсердия и гистологическое строение легких и сердца с такой же эффективностью, как препарат сравнения риоцигуат в дозе 5 мг/сут.

  • Open Access

    Expert consensus on approaches to risk stratification and choice of therapy in patients with inoperable and residual chronic thromboembolic pulmonary hypertension

    by I E Chazova, T V Martynyuk, S N Avdeev, Z S Valieva, O Y Vasiltseva, T N Veselova, V V Gramovich, D S Grankin, N M Danilov, A G Edemskiy, et al.

    On December 13, 2024, the final working group meeting was held, the purpose of which was to discuss the common position of experts on the problem of chronic thromboembolic pulmonary hypertension of various specialties: cardiologists, cardiac surgeons, pulmonologists, on issues of assessing the operability of patients, risk stratification and choice of therapy in patients with inoperable and residual forms of pathology. The discussion field included a wide range of issues that often arise in real clinical practice, but specific answers to them are not given in national and foreign guidelines. On November 8, 2024, at the preparatory stage, 16 experts under the leadership of Academician of the Russian Academy of Sciences I.E. Chazova (chairman) formulated questions for the preparation of a consensus document (without discussion), consistently discussing the feasibility of including each issue in the document and distributing tasks for the final session. Then, at the intermediate stage, experts searched and systematized scientific information on the formulated questions in the PubMed and eLIBRARY systems to prepare sections of the document in accordance with the established tasks. When finalizing the document, experts answered 28 questions: during anonymous voting an individual score was determined for each block from 1 – completely disagree, to 5 – completely agree. It was considered that a strong consensus was achieved with a mean score of M±m 2.5±2, and with a mean score below 2.5, consensus was not achieved. A strong consensus was reached on all issues.


  • Open Access

    Reserve capabilities of the cardiovascular and respiratory systems in patients with chronic thromboembolic pulmonary hypertension

    by O. Ya. Vasiltseva, D. F. Zeynalov, A. G. Edemsky, D. S. Grankin, A. G. Lavrov, D. A. Sirota, A. M. Chernyavskiy, О. Я. Васильцева

    Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious disease associated with thrombotic lesions of the pulmonary arteries and secondary microvasculopathy, leading to the progression of pulmonary hypertension and heart failure. Pulmonary endarterectomy (PEA) is the preferred treatment for CTEPH.Aim: To study the reserve capabilities of the cardiovascular and respiratory systems in patients with CTEPH.Material and Methods. The retrospective cohort observational study included 403 patients aged 19 to 77 years with CTEPH who underwent PEA at the National Medical Research Center named after. ak. E.N. Meshalkin from 2004 to 2021. Parameters of transthoracic echocardiography, pulmonary circulation tensiometry, pulmonary function tests, six-minute walk test and Borg scale were assessed before surgery, after PEA before discharge and after surgery 12 months later.Results. When comparing transthoracic echocardiography data at the hospital stage after PEA, a decrease in right ventricular systolic pressure was revealed from 82.2 ± 23.1 to 44.9 ± 16.2 mm Hg, leading to an improvement in intracardiac hemodynamics, characterizing the right heart function. These improvements continued into the long-term follow-up. Analysis of pulmonary circulation tensiometry in CTEPH patients after PEA showed that all patients had a significant decrease in mean pulmonary artery pressure from 48.3 ± 14.5 to 27.1 ± 10.7 mmHg (by 1.8 times), which was accompanied by a decrease in pulmonary vascular resistance by 2.8 times and an increase in cardiac output. In the long-term follow-up improvements in the pulmonary circulation tensiometry indicators also persisted. When comparing the indicators of pulmonary function tests, a statistically significant decrease in tidal and minute respiratory volumes was revealed. After PEA six-minute walk test distance increased by 19.0 meters, in the long-term follow-up by 60.6 meters; shortness of breath according to the Borg scale decreased from “severe” to “moderate”, in the long-term follow-up to “mild”.Conclusion. The results obtained demonstrate the continuation of the cardiovascular and respiratory systems recovery processes in the immediate postoperative period, and further during the year of observation after PEA, indicate significant reserve capabilities of the cardiovascular and respiratory systems, and the potential cure of patients with CTEPH.

  • Open Access

    Russian consensus: balloon pulmonary angioplasty in treatment of chronic thromboembolic pulmonary hypertension

    by N. M. Danilov, Yu. G. Matchin, D. S. Grankin, N. V. Marukyan, S. Y. Yarovoy, N. A. Androsov, E. M. Elfimova, Yu. V. Danilushkin, T. V. Martynyuk, K. V. Mershin, et al.

    For a long time, the only method of revascularization in patients with chronic thromboembolic pulmonary hypertension (CTEPH) was pulmonary thromboendarterectomy from the branches of pulmonary artery. Transluminal balloon pulmonary angioplasty (BPA), as an alternative treatment option for inoperable and residual CTEPH, appeared recently, but has already firmly taken its place in the treatment algorithm of CTEPH, and has significantly improved the prognosis in such patients. Active use of BPA in everyday practice served as the reason for the creation of this consensus in order to summarize and systematize modern data on patient selection, technique and goals of endovascular treatment, prevention and treatment of complications. The document additionally covers the issues of visualization of the pulmonary arteries, complex variants of damage and describes an algorithm for the prevention and treatment of pulmonary injury after BPA. The recommendations provided in the consensus are based on the results of national and foreign studies, the experience of experts and are intended for specialists who are part of a multidisciplinary team for the management of patients with CTEPH (cardiologists, endovascular and cardiovascular surgeons), as well as pulmonologists, radiation diagnosticians and physicians.


  • Open Access

    Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: short- and long-term results

    by A.G. Badoian, D.S. Grankin, O.V. Krestyaninov, U.SH. Sharafutdinov, S.N. Manukian, A.A. Baranov, D.A. Khelimskii

    Background: Data on the short-term efficacy and safety of balloon pulmonary angioplasty (BPA) in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) are widely presented in the world literature; meanwhile information on long-term patient outcomes is very limited. Objective: The study aimed at the assessing of the short- and long-term results of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension who completed all BPA sessions. Methods: We conducted a retrospective data analysis on 144 patients with a diagnosis of CTEPH who have completed BPA series in the common center from August 2015 through April 2023. Clinical and procedural results including the data from right heart catheterization, as well as long-term outcomes were collected and evaluated. Nonparametric rank sum tests were used to assess changes in hemodynamic parameters of the pulmonary artery before and after BPA. Survival analysis was performed using the Kaplan-Meier method: the impact of individual and procedure-related factors on the occurrence of death in the long-term follow-up period was assessed with univariate and multivariate logistic regressions. Results: A total of 446 BPA sessions were performed across 144 patients. The median value of mean pulmonary artery pressure (mPAP) decreased significantly by 9 mmHg (from 41 to 32). Out of 446 BPA sessions, there were 4 periprocedural deaths (0.9% of the number of procedures and 2.7% of the number of patients). Of the 134 patients available for contact, 26 (19.4%) died in the long-term period. Overall, 1- and 3- year survival probabilities were 93% and 82%, respectively. Multivariable logistic regression analysis showed that the chronic obstructive pulmonary disease (OR: 7.8 (1.86, 36.7), p = 0.006), coronary artery disease (OR: 3.78 (1.28, 11.2), p = 0.02) and a smaller decrease of mPAP after last BPA (OR: 0.91 (0.86, 0.97), p = 0.003) were independently associated with a death at follow-up period. Additional receiver operating characteristic (ROC) analysis revealed that a change in mPAP by 4.5 mmHg was the most effective predictor of death at follow-up with sensitivity and specificity equal to 0.68 and 0.60, respectively. Conclusion: Balloon pulmonary angioplasty in patients with CTEPH is a safe procedure with significant enhancement of pulmonary hemodynamics but long-term results remain still unsatisfactory that emphasizes the complexity of this cohort of patients and the demand for developing algorithms for their treatment and monitoring. Received 26 June 2024. Revised 26 July 2024. Accepted 1 October 2024. Funding The study did not have sponsorship. Conflict of interest The authors declare no conflict of interest. Contribution of the authorsConception and study design: A.G. Badoian, O.V. KrestyaninovData collection and analysis: A.G. Badoian, U.Sh. Sharafutdinov, S.N. ManukianStatistical analysis: A.G. Badoian, A.A. BaranovDrafting the article: A.G. Badoian, A.A. Baranov, D.A. Khelimskii, D.S. GrankinCritical revision of the article: O.V. Krestyaninov, D.S. GrankinFinal approval of the version to be published: A.G. Badoian, D.S. Grankin, O.V. Krestyaninov, U.Sh. Sharafutdinov, S.N. Manukian, A.A. Baranov, D.A. Khelimskii


  • Open Access

    CORONARY ARTERY CALCIFICATION: INTRACORONARY IMAGING, CONTEMPORARY TECHNOLOGIES OF TREATMENT

    by Aryuna Yu. Tsydenova, Алексей Алексеевич Баранов, Roman A. Naydenov, Руслан Увэйсович Ибрагимов, Денис Сергеевич Гранкин, Oleg V. Krestyaninov, Арюна Юрьевна Цыденова

    HighlightsThis review presents current state-of-the-art of diagnosis and treatment of coronary artery calcification. AbstractCoronary artery calcification occurs in about one third of all coronary artery lesions in patients with coronary artery diseases and is a problem in interventional cardiology due to technical difficulties. Percutaneous coronary intervention for coronary artery calcification is associated with a high risk of perioperative complications, adverse cardiovascular events in early and long-term follow-up compared with the results of treatment of patients without arterial calcification. One of the most important predictors of a favorable outcome after implantation of a drug-eluting stent is the optimal cross-sectional area of coronary stent. Intravascular imaging plays an important role in lesion assessment, selection of instruments and optimization of stent implantation, contemporary technologies modification of severe coronary artery calcification, as well as their combination, will probably lead to better procedural success and long-term results.


  • Open Access

    Pigs as Models to Test Cardiovascular Devices

    by Yanina L. Rusakova, Denis S. Grankin, Kseniya S. Podolskaya, Irina Yu. Zhuravleva

    Pigs as laboratory animals are used in preclinical studies aimed at developing medical devices for cardiac surgery. The anatomy of the cardiovascular system of these animals has been well studied and acknowledged as suitable for use and the testing of new cardiovascular devices developed for humans. However, there are no morphometric characteristics of the aortic root and thoraco-abdominal part of porcine aorta. This can lead to difficulties in experimental surgery and even result in the death of experimental animals due to the mismatch in the size of the implantable devices. Thus, such information is essential to enhance the efficiency of surgical technologies used for eliminating aortic pathologies in their various sections. The purpose of our research is to study the anatomy of the aorta in mini pigs and to assess whether the size, age, and sex of the animals affect the size of the main structures in their aortas. In addition, we attempted to compare the results obtained by transesophageal echocardiography (TEE) and angiography. We studied 28 laboratory mini pigs, dividing them into three groups by body weight (40–70 kg, 71–90 kg, and 90 kg). We did not find any relationship between the external somatometric characteristics of the animals and the size of their aortas. Animals have individual anatomical variability in their cardiovascular systems, which means that they need to be examined in terms of preoperative planning by any available method—echocardiography, angiography, or multispiral computed tomography (CT).


  • Open Access

    A Pig as a Model to Test Cardiovascular Devices

    by Yanina L. Rusakova, Denis S Grankin, Kseniya S. Yu. Podolskaya, Irina Yu. Jhuravleva

    Pigs are used as laboratory animals in preclinical studies on medical devices for cardiac surgery. On the one hand, the anatomy of the cardiovascular system of these animals has been well studied and acknowledged suitable for use and testing of new cardiovascular devices developed for humans. On the other hand, there are no morphometric characteristics of the aortic root and other parts of it in pigs with different weights. This can lead to difficulties in the work of researchers and even result in the death of experimental animals due to the discrepancy in the size of the implantable devices. Thus, such information is essential to improve the efficiency of surgical technologies used in the correction of aortic pathologies in its various sections. The purpose of our research is to study the anatomy of the aorta in mini-pigs, and to assess whether the size, age, and sex of animals affect the size of the main structures in their aorta. In addition, we attempted to compare the results obtained by the method of transesophageal echocardiography (TEE) and angiography. We studied 28 laboratory mini-pigs weighing from 40 to 105 kg, and then we compared our results with other studies and did not find any relationship between the external somatometric characteristics of animals and the size of their aorta. Each animal has an individual anatomy, so they are to be examined in terms of preoperative planning by any available method - echocardiography, angiography or multispiral computed tomography (MRI).

  • Open Access

    Therapies of chronic thromboembolic pulmonary hypertension: A review

    by Oksana Vasiltseva, Alexander Edemskiy, Devran Zeinalov, Elena Kliver, Wladimir Ussov, Denis Grankin, Dmitry Sirota, Aleksandr Chernyavskiy

    The article addresses therapies for chronic thromboembolic pulmonary hypertension (CTEPH). The main challenges of patient management at various stages of diagnosis and treatment and the prevalence and pathogenesis of CTEPH are described. Immediate and long-term outcomes after treatment are evaluated. The study aims to present current therapies for CTEPH.